Stuart Ellison

Dr. Stuart Ellison is an academic researcher affiliated with the University of Manchester, contributing to the UN Sustainable Development Goals through his work in medical research. He leads projects in the Stem Cell and Neurotherapies group, focusing on gene and stem cell therapies for disorders like Mucopolysaccharidosis and neurodegenerative diseases. His expertise spans preclinical studies, lentiviral vector development, and GMP-compliant cell manufacturing.

Education:

• Bachelor of Science in Biochemistry with Molecular Biology (2004), UMIST
• PhD in Cardiovascular Sciences (2010), University of Birmingham

Research Interests: His work bridges biochemistry and clinical applications, emphasizing:
- Gene therapy for neuromuscular and neurological disorders
- Stem cell-based treatment strategies for lysosomal storage diseases
- Development of novel viral vectors for targeted drug delivery

Publications Trends: Recent articles highlight advancements in MPS therapies, neurodegeneration mechanisms, and immune system interactions in lysosomal diseases. Collaborations focus on translating preclinical findings into clinical applications.

Labs/Teams: Active within the Stem Cell and Neurotherapies group at the University of Manchester, contributing to interdisciplinary research in regenerative medicine and genetic therapies.